Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Alcohol Use Disorder stories

May 2, 2026

GLP-1 Drug Semaglutide Reduces Heavy Drinking Days by 50% in Alcohol Use Disorder Trial

A clinical trial of 108 adults with obesity and alcohol use disorder found that once-weekly semaglutide injections reduced heavy drinking days in the past 30 days by an average of roughly 12 days, representing a 50% reduction compared to placebo.

May 2, 2026·1 source
00

Top claims

  • ▪The semaglutide alcohol use disorder trial included 108 adults
  • ▪The semaglutide alcohol use disorder study is published in The Lancet
  • ▪The semaglutide alcohol use disorder trial results could support regulatory approval for new treatment indications

Subtopics

Addiction & recovery1Addiction and Harm Reduction1Clinical trials1Drug supplement interactions1Evidence based supplementation1GLP-1 medications1Lifestyle, Wellness and Nutrition1Mental Health & Wellbeing1Weight loss medications & GLP-1 drugs1Weight management1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories